Home/Pipeline/EMROSI (minocycline hydrochloride) extended-release capsules, 40mg

EMROSI (minocycline hydrochloride) extended-release capsules, 40mg

Inflammatory Lesions of Rosacea

Approved/CommercialMarketed

Key Facts

Indication
Inflammatory Lesions of Rosacea
Phase
Approved/Commercial
Status
Marketed
Company

About Journey Medical

Journey Medical Corporation is a commercial-stage dermatology company with a mission to improve patient well-being by providing effective solutions for treating skin conditions. Its core strategy involves identifying, acquiring, and strategically commercializing innovative, differentiated dermatology products through a lean, experienced commercial team. As a publicly traded subsidiary of Fortress Biotech, the company has built a portfolio of approved products and employs an asset-light, acquisition-driven model to grow within the specialty dermatology market.

View full company profile

Therapeutic Areas